Equity Transactions (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Common stock issued during period for acquisition value			$ 35,000
Shares of common stock for consulting service, value			$ 175,000
Common stock for prepayment of interest on note payable			134,000
Common stock issued during period for acquisition value	$ 0	$ 33,740
Common stock issued during period for acquisition				4,000,000
VitaMedica [Member]
Common stock issued during period for acquisition value			$ 100,000
Common stock issued during period for acquisition			482,000
FinderFee [Member]
Common stock issued during period for acquisition value			$ 33,740
Common stock issued during period for acquisition			7,000
Common Stock Shares [Member]
Shares of common stock for consulting service, value			$ 4,000,000
Common stock issued during period for acquisition value			$ 6,000,000
Common stock issued during period for acquisition			1,247,403
Shares of common stock for consulting service, shares			666,667
Common Stocks [Member] | Infusionz [Member]
Common stock issued during period for acquisition value			$ 1,764,876
Common stock issued during period for acquisition			306,945
Convertible Preferred Stock [Member]
Sale of preferred stock shares			500,000
Preferred stock convertible into shares of common stock ratio			The preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share